Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Octapharma Sweden AB
AB
In liquidation
Org 5593595274
Stockholm
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2022
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Octapharma Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
0
0
Staff expenses
—
—
EBITDA
−35
—
Depreciation & amort.
−0
−0
EBIT
−35
0
Net financials
12
23
Profit before tax
−35
23
Tax
−0
−0
Net profit
−35
23
Balance sheet
SEK thousands
Item
2023
2024
Total assets
1 204
1 215
Equity
0
34
Long-term debt
0
0
Short-term debt
1 192
1 181
Total debt
1 192
1 181
Financial ratios
5-year trend
EBITDA-margin
0.0%
This company
15.8%
Market median
-100% vs market
2023
2024
Soliditetsgrad
2.8%
This company
38.2%
Market median
-93% vs market
2023
2024
Egenkapitalforrentning
67.6%
This company
18.4%
Market median
+267% vs market
2023
2024
Nettoresultatgrad
2300000.0%
This company
8.1%
Market median
+28394962% vs market
2023
2024
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2023
2024
Gæld/egenkapital
34.74×
This company
0.62×
Market median
-5503% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2023-06-30
View
PDF
More on Octapharma Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
